cdmo.directory
← Compare landing

AGC Biologics vs Yapan Bio

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAGC BiologicsYapan Bio
SummaryGlobal CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.Yapan Bio provides integrated process development, characterization, and GMP manufacturing for vaccines, monoclonal antibodies, gene therapy, and viral vector-based biologics, with capabilities up to 1000L bioreactor scale and BSL-2+ containment.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Microbial Fermentation
  • Viral Vector Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Prefilled Syringes (PFS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Headquarters, Seattle, Washington, USA
  • Copenhagen, Copenhagen, Denmark
  • Heidelberg, Heidelberg, Germany
  • Milan, Milan, Italy
  • Chiba, Chiba, Japan
  • Yokohama, Yokohama, Japan
  • 450 GMP Facility, Hyderabad, Telangana, India
  • Process Development Facility, Hyderabad, Telangana, India
  • 270 GMP Facility, Hyderabad, Telangana, India
CertificationsData not yet provided.Data not yet provided.

Find similar companies

AGC Biologics alternatives · Yapan Bio alternatives

Markdown mirror: /compare/agcbio/yapan-bio.md